Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics vs Antibiotics in Chronic Periodontitis
NCT03499184Completed
- Sponsor
- Ziauddin Hospital
- Start
- Nov 2017
- Primary completion
- Sep 2018
- Modality
- Microbiome Therapeutics, Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of lactobacillus reuteri in chronic periodontitis (3 arms), sponsored by Ziauddin Hospital. Primary endpoints: Periodontal Pocket Depth at 12 weeks, Clinical Attachment Level at 12 weeks and 1 more. Started Nov 2017; status: completed.
02
Drugs
lactobacillus reuteri
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT03499184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499184.